TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs

► TOX4/PNUTS/WDR82 complex interacts with DNA damaged by anticancer platinum drugs. ► SPRi shows that TOX4 affinity for platinum adducts is weaker than that of HMGB1. ► Plasmid probes and proteomics allow identification of damaged DNA interactome.